Osteoarthritis - The Lancet
Osteoarthritis in 2020 and beyond: a Lancet Commission - The Lancet
Osteoarthritis - The Lancet
Osteoarthritis: pathogenic signaling pathways and therapeutic targets | Signal Transduction and Targeted Therapy
Frontiers | Synovial Macrophages in Osteoarthritis: The Key to Understanding Pathogenesis?
Pathogenesis and management of pain in osteoarthritis - The Lancet
Frontiers | Non-viral Gene Therapy for Osteoarthritis
Osteoarthritis - The Lancet
One billion people globally to have osteoarthritis by 2050: Lancet Study | The Financial Express
Pathogenesis and management of pain in osteoarthritis - The Lancet
Osteoarthritis Analysed In Lancet Study | Latest Update | Drishti IAS English - YouTube
Clinical update: treating osteoarthritis - The Lancet
Around 1 bn people globally will live with osteoarthritis by 2050, says Lancet study - The Economic Times
Osteoarthritis - The Lancet
What Is Osteoarthritis? | Arthritis-health
Osteoarthritis - The Lancet
Osteoarthritis: an update with relevance for clinical practice - The Lancet
Osteoarthritis - The Lancet
Osteoarthritis - The Lancet
IJMS | Free Full-Text | Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis
Biology | Free Full-Text | Pathogenesis of Osteoarthritis: Risk Factors, Regulatory Pathways in Chondrocytes, and Experimental Models
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 - The Lancet Rheumatology
 "One Billion People Globally To Have Osteoarthritis By 2050: Lancet Study")
One Billion People Globally To Have Osteoarthritis By 2050: Lancet Study
